Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2024-08-06 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges of upcoming investor meetings and explicitly states that no unpublished price sensitive information will be shared. The document is short (1595 characters) and does not contain any financial data, results, or detailed presentations. It is an announcement of a meeting schedule rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-08-06 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of meetings with analysts and institutional investors. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of events or information. The content is an announcement of a scheduled investor meeting, explicitly stating no unpublished price sensitive information will be shared. The document is short (1595 characters) and does not contain any financial data, results, or detailed presentations. It is an announcement related to investor relations but not a full investor presentation or financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated July 31, 2024, addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which mandates disclosure of such meetings. The document explicitly states that no unpublished price sensitive information will be shared. There is no financial data, report, or detailed presentation included, only an announcement of a scheduled meeting. The document length is 1542 characters, which is short and consistent with an announcement rather than a full report or transcript. Therefore, this fits best under Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like Investor Presentation or Call Transcript, since it only announces a meeting schedule without content of the meeting itself.
2024-07-31 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a short notice dated July 31, 2024, addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30(6). The content is an announcement of a future meeting with analysts and investors, explicitly stating no unpublished price sensitive information will be shared. The document is brief (1542 characters) and does not contain any financial data, report content, or detailed presentation materials. It is an announcement related to investor relations but not a full investor presentation or financial report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-07-31 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges, referencing a regulatory requirement under SEBI Listing Regulations. It informs about the filing of an appeal related to a tax demand order and states there is no material impact on financials. The document is dated July 30, 2024, and mentions previous correspondence. It does not contain any financial statements, detailed financial data, or comprehensive report content. The length is only 1739 characters, which is quite short and more of an announcement or update rather than a full report. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a certification or officer attestation document. It is an update on a legal/regulatory matter related to tax appeal, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories specifically.
2024-07-30 English
Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges, referencing a regulatory requirement under SEBI Listing Regulations. It informs about the filing of an appeal related to a tax demand order and states there is no material impact on financials. The letter is dated July 30, 2024, and mentions previous correspondence. The content is an update on a legal/tax matter, not a full report or financial statement. The document length is only 1739 characters, indicating it is a brief announcement rather than a detailed report. It does not contain financial statements or detailed analysis, nor is it a certification or voting result. It fits best as a Regulatory Filing (RNS) since it is a compliance-related announcement that does not fit other specific categories.
2024-07-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.